BVS (Bioventus) Float Percentage Of Total Shares Outstanding: 68.41% (As of Jun. 30, 2026)


BVS Bioventus Inc BVS
66 GF Score
Price $9.44
GF Value $6.79
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bioventus Float Percentage Of Total Shares Outstanding?

Bioventus BVS -3.48% 66 Float Percentage Of Total Shares Outstanding is 68.41% as of Jun. 30, 2026. GuruFocus rates BVS with a GF Score™ of 66/100 and a GF Value™ of $6.79 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bioventus's float shares is 46.35 Mil. Bioventus's total shares outstanding is 67.75 Mil. Bioventus's float percentage of total shares outstanding is 68.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bioventus's Insider Ownership is 6.97%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bioventus's Institutional Ownership is 80.05%.

BVS
66GF Score
Bioventus Inc BVS
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioventus Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Bioventus's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=46.35/67.75
=68.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 68.41% mean?
Bioventus (BVS) has a Float Percentage Of Total Shares Outstanding of 68.41% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Bioventus and its competitors.
Is Bioventus' Float Percentage Of Total Shares Outstanding too high?
Bioventus' current Float Percentage Of Total Shares Outstanding is 68.41%. Overall, Bioventus has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bioventus' Float Percentage Of Total Shares Outstanding compare to SSII and TCMD?
Bioventus' Float Percentage Of Total Shares Outstanding of 68.41% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Bioventus and its competitors. Bioventus's current Float Percentage Of Total Shares Outstanding is 68.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioventus stock overvalued right now?
Based on GuruFocus' analysis, Bioventus (BVS) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.79, compared to a current price of $9.44 — trading 39% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 68.41%. Bioventus' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Bioventus (BVS), the current Float Percentage Of Total Shares Outstanding is 68.41% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioventus (BVS) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventus stock appears to be overvalued. The current stock price of $9.44 is trading 39% above its estimated GF Value™ of $6.79. GuruFocus considers Bioventus to be Significantly Overvalued.

Key valuation signals for BVS:

  • Float Percentage Of Total Shares Outstanding: 68.41%
  • GF Value™: $6.79 vs. price of $9.44 (39% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the BVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventus Business Description

Other Exchanges 4B8:Germany
Address 4721 Emperor Boulevard, Suite 100, Durham, NC, USA, 27703
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
66GF Score

Get the complete analysis for BVS

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.44
Price
$6.79
GF Value